Denali Therapeutics Stock Discussion

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

$Denali Therapeutics (DNLI.US)$ 👀

$Pfizer (PFE.US)$  Phase 2
$Leap Therapeutics (LPTX.US)$  Phase 2
$Vera Therapeutics (VERA.US)$  Phase 2b
$4D Molecular Therapeutics (FDMT.US)$  Phase 2
$Adverum Biotechnologies (ADVM.US)$  Phase 2
$Denali Therapeutics (DNLI.US)$  Phase 2
$Akero Therapeutics (AKRO.US)$  Phase 2b
$Spruce Biosciences (SPRB.US)$  Phase 2
$Xencor (XNCR.US)$  Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$  Phase 2
$Harmony Biosciences (HRMY.US)$  Phase 2
$Annexon (ANNX.US)$  Phase 2a
$Roivant Sciences (ROIV.US)$...

$Cellectar BioSciences (CLRB.US)$ Phase 2
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2...